Literature DB >> 18206520

Rhabdomyosarcoma.

Arnold C Paulino1, Mehmet Fatih Okcu.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18206520     DOI: 10.1016/j.currproblcancer.2007.11.001

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  33 in total

1.  A set of imprinted genes required for normal body growth also promotes growth of rhabdomyosarcoma cells.

Authors:  Geoffrey Rezvani; Julian C K Lui; Kevin M Barnes; Jeffrey Baron
Journal:  Pediatr Res       Date:  2012-01       Impact factor: 3.756

2.  Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state.

Authors:  Min-Hyung Lee; Mathivanan Jothi; Andrei V Gudkov; Asoke K Mal
Journal:  Cancer Res       Date:  2011-04-14       Impact factor: 12.701

3.  Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Sandeep Sreevalsan; Satya Pathi; Kyounghyun Kim; Candy Chen; Lisa Crose; Corinne Linardic; Stephen Safe
Journal:  Int J Cancer       Date:  2012-08-03       Impact factor: 7.396

4.  Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma.

Authors:  Alexandra Lacey; Erik Hedrick; Yating Cheng; Kumaravel Mohankumar; Melanie Warren; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2018-09-06       Impact factor: 6.261

5.  Spindle cell rhabdomyosarcoma in the hypopharynx of an adult.

Authors:  Ting-Ting Wu; Qin-Ying Wang; Shui-Hong Zhou; Zhou-Jun Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

6.  Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas.

Authors:  Sarah E Mahoney; Zizhen Yao; C Chip Keyes; Stephen J Tapscott; Scott J Diede
Journal:  Epigenetics       Date:  2012-04-01       Impact factor: 4.528

7.  PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1.

Authors:  Alexandra Lacey; Aline Rodrigues-Hoffman; Stephen Safe
Journal:  Cancer Res       Date:  2016-11-18       Impact factor: 12.701

8.  Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas.

Authors:  Kaiji Hu; Cathy Lee; Dexin Qiu; Abbas Fotovati; Alastair Davies; Samah Abu-Ali; Daniel Wai; Elizabeth R Lawlor; Timothy J Triche; Catherine J Pallen; Sandra E Dunn
Journal:  Mol Cancer Ther       Date:  2009-11-03       Impact factor: 6.261

9.  Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice.

Authors:  Richard L Price; Katherine Bingmer; Lualhati Harkins; O Hans Iwenofu; Chang-Hyuk Kwon; Charles Cook; Christopher Pelloski; E Antonio Chiocca
Journal:  Cancer Res       Date:  2012-09-21       Impact factor: 12.701

Review 10.  Herpes simplex virus oncolytic therapy for pediatric malignancies.

Authors:  Gregory K Friedman; Joseph G Pressey; Alyssa T Reddy; James M Markert; G Yancey Gillespie
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.